Mounjaro®
Starting from £179.99/mo
Start journey Learn moreOne complete dose of Mounjaro is delivered when the KwikPen has been held in place until the click counter stops and the yellow indicator has moved fully. The pen does not require you to count individual clicks to reach your dose — instead, a single press and hold delivers the full amount. That said, understanding what each stage of the injection process sounds and feels like is the question most people have after their first pen arrives. Mounjaro is a prescription-only medicine requiring a clinical assessment before it can be prescribed, and your Patient Information Leaflet is the definitive reference for your specific pen and dose.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro KwikPen is a pre-filled, multi-dose device. According to the Mounjaro Summary of Product Characteristics published on the electronic Medicines Compendium (eMC), each pen contains four weekly doses at the labelled strength. You do not count individual audible clicks to measure your dose. The injection works differently: you place the pen against the skin, press the plunger button down, and hold it there. During that hold, you will typically hear a first click when the injection begins and a second click when the full dose has been delivered. The yellow indicator moving across the window is the visual confirmation that medicine is flowing.
Holding the pen steady for a slow count of ten seconds after the second click (before removing it from the skin) is the step the patient leaflet emphasises most, because pulling away too soon can cut the dose short. The number on the dose counter drops from its starting value of four toward zero as you use the pen across four weeks. That counter is your record of doses remaining, not a measure of how much of the current injection has gone in.
If you want to cross-reference the volume involved, the guide to Mounjaro dose volumes explains what the KwikPen delivers in millilitres at each strength, which some people find useful context alongside the mechanical steps.
The question about clicks is understandable. Older-style injectable devices, including some insulin pens that many patients have experience with, did require dialling up a specific number of units and counting movements. The KwikPen is a fixed-dose design: the device is set at the factory to release one complete dose per activation. There is no dial, no unit wheel, and no click-counting required on your part.
The two audible clicks serve as confirmation signals, not counting steps. Some people hear both clearly; others, particularly through thicker clothing or at certain injection sites, hear only one or find the distinction muffled. The yellow indicator window is the more reliable guide in those cases. If the indicator has not moved, the dose has not been delivered. Our frequently asked questions cover some of the other practical concerns people raise once they start using the pen.
For anyone curious about whether a partial press is possible, the related question of what constitutes half a dose of Mounjaro is worth reading, but splitting a dose is not something to attempt outside explicit prescriber guidance, and the KwikPen is not designed for it.
Each KwikPen is labelled with its strength: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg or 15 mg. The mechanics of the click and hold are the same across all six strengths, but the concentration of tirzepatide delivered per press differs. Treatment typically begins at 2.5 mg (the first pen exists to help your system adjust gradually, not as the main therapeutic dose) and is titrated by your prescriber in steps, usually at four-week intervals, and if you are moving from the starter pen to the next strength it is worth reading our explanation of how many clicks the 2.5 mg dose involves on the 5 mg pen before you make the switch. The NHS tirzepatide medicines page gives a plain-language overview of how the treatment course works alongside diet and activity.
Because the device is identical in feel and size at every strength, it can be easy to forget which pen you are on when doses change. Writing the strength and start date on the pen with a marker, or noting it in your phone, is a small habit that saves confusion later. If you are ever uncertain whether a dose went in correctly (the indicator did not move, or you removed the pen early) contact your prescriber rather than administering another injection. Your aftercare team at nume is available seven days a week for exactly this kind of question.
For a broader look at the 5 mg pen specifically, including what to expect at that stage of titration, the Mounjaro 5 mg guide covers the clinical picture in more detail.
Good injection technique is consistent: rotate sites between the abdomen, thigh and upper arm week to week; clean the site before injecting; keep the pen pressed fully against the skin until that slow count is done. The Patient Information Leaflet that comes inside the box illustrates each step. It is written specifically for your pen strength and is the document your prescriber expects you to use as your primary reference for the physical process.
If the pen feels like it has not clicked, or the yellow indicator window looks the same before and after, that is the moment to stop and check the leaflet before trying again. The guide on tirzepatide unit conversions may help if you have received your pen after previously using a different injectable and are trying to map the two together.
Mounjaro is licensed for weight management in adults with a BMI of 30 or above, or 27 or above alongside a qualifying weight-related condition. NICE recommends tirzepatide in technology appraisal TA1026 for eligible adults within the NHS pathway; private prescriptions follow the licensed criteria directly. If you are weighing up treatment options or want to understand the full picture before committing, start a free consultation and a GPhC-registered prescriber will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.